| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 4 |
| 1 | TACROLIMUS | 4 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 4 |
| 3 | TACROLIMUS OINTMENT 0.1% | 4 |
| 4 | ACETAMINOPHEN,CAFFEINE | 1 |
| 5 | ADALIMUMAB-ADAZ | 1 |
| 6 | BREXPIPRAZOLE | 1 |
| 7 | GLATIRAMER | 1 |
| 8 | GLATIRAMER ACETATE | 1 |
| 9 | GLATIRAMER ACETATE INJECTION | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MARIBAVIR | 1 | 0.0004 |
| 1 | GLATIRAMER ACETATE INJECTION | 1 | 0.0002 |
| 2 | SIROLIMUS | 1 | 0.0001 |
| 3 | BREXPIPRAZOLE | 1 | 0.0001 |
| 4 | INTERFERON BETA-1B | 1 | 0.0001 |
| 5 | MYCOPHENILIC ACID | 1 | 0.0000 |
| 6 | TACROLIMUS OINTMENT 0.1% | 4 | 0.0000 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 4 | 0.0000 |
| 8 | MYCOPHENOLIC ACID | 1 | 0.0000 |
| 9 | TACROLIMUS | 4 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0004 |
| 1 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 2 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 3 | Methylxanthine [EPC] | 1 | 0.0000 |
| 4 | Central Nervous System Stimulant [EPC] | 1 | 0.0000 |
| 5 | Aldosterone Antagonist [EPC] | 1 | 0.0000 |
| 6 | Interferon beta [EPC] | 1 | 0.0000 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 5 | 0.0000 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 9 | Atypical Antipsychotic [EPC] | 1 | 0.0000 |